News

State of Innovation: R.I.’s ecosystem for entrepreneurs shows resilience

RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company

New Fund Participates in Series A Financing for URI-Based MindImmune, Developer of a Novel Treatment for Neuroinflammatory Conditions Such as Alzheimer’s Disease

Noted Scientist Nancy Ryan Gray and Brown University Engineering Dean Lawrence Larson Join the Slater Board; Larson Named Chair

There’s a New Implant Developed in Rhode Island to Treat Spine Fractures

RightHill Ventures Launches to Accelerate the Journey from Research to Startup for University Innovations

Arctura Awarded $1.15 Million Grant from U.S. Dept. of Energy

Arctura has won a $1.15-million Phase IIB SBIR grant from the U.S. Department of Energy (DOE) to commercialize a new blade coating designed to reduce the damage to wind turbine blades caused by lightning.

Slater-Backed Company Acquired by Novartis

The Slater Technology Fund, Rhode Island’s oldest and most active seed-stage investment fund, applauds the team at Cadent Therapeutics, who today announced that the company has entered into an agreement to be acquired by global healthcare giant Novartis [NYSE: NVS] in a deal worth up to $770 million.